Background
Abstract
Background Improving postoperative pain and other potential benefits of IV lidocaine remains a significant debate in elderly patients. This meta-analysis aims to estimate the effect perioperative continuous IV lidocaine in elderly patients undergoing surgery.
Method
Pubmed/Medline, Web of Science, Embase and CENTRAL through OVID SP were independently searched until November 1, 2019 by two authors. This systematic review and meta-analysis included all randomized controlled trials that compared the effect of continuous IV lidocaine and any placebo or no treatment in aged patients after surgery.
Primary outcomes were length of hospital stay and postoperative pain score and second outcomes were postoperative nausea and vomiting, opioid consumption, gastrointestinal recovery and postoperative neuropsychological function status scale.
Result
Eighteen studies(1175 patients) were included. Meta-analysis suggested that IV lidocaine reduce the postoperative pain scores(visual analogue scale, 0-10cm) at 2h(SMD:-1.30, 95% CI -1.90 to -0.70), 4h(SMD:-1.20, 95% CI -1.91 to -0.49), 6h(SMD:-0.87, 95%CI -1.72 to 0.02), 8h(SMD:-0.84, 95%CI -1.40 to -0.27), 12h(SMD:-0.73, 95%CI -1.14 to -0.32), 24h(SMD:-0.39, 95%CI -0.66 to -0.11), shorten length of hospital stay(MD: -0.30, 95%CI -0.50 to -0.09), decrease the requirement of opioid drugs(SMD: -0.31, 95%CI -0.31 to -0.01) and the incidence of postoperative nausea(OR: 0.52, 95%CI 0.31 to 0.87) in elderly patients undergoing surgery.
Conclusion
The evidence suggested that IV lidocaine significantly reduce postoperative pain intensity and opioid consumption and shorten the length of hospital stay in aged patients. In addition, it was shown that IV lidocaine decrease the requirement of postoperative opioid and incidence of postoperative nausea compared to control group. IV lidocaine maybe a useful assistant during general anesthesia owing to its beneficial effect in several outcomes in geratic patients undergoing surgery.
Background
Postoperative pain management is a major focus after surgery, especially in the field of fast-track surgery, which aims to prevent or reduce common complications including postoperative pain,postoperative nausea and vomiting hypercoagulation deep venous thrombosis, ileus and postoperative cognitive dysfunction and speed up early recovery, in elderly patients [1] [2] [3] [4] .The number of major operations of all over the world annually approaches 250 million [5] with no less than 33 percent of surgical patients over 65 year [6, 7] and evidence reveals that postoperative pain and ileus causing extended length of hospital stay are the primary hospitalization expenses driver in the postoperative period [8, 9] .Postoperative pain control after surgery in elderly patients has been become a serious clinical problem that many strategies have been applied to decrease postoperative pain and length of hospital stay, containing steroidal anti-inflammation drugs, nonsteroidal anti-inflammatory drug (NSAID) opioid drugs, patient controlled analgesia (PCA) and local anesthesia [10] [11] [12] . Nevertheless none of them has indicated identical efficacy and opioid medications can caused side effects including nausea and vomiting, megrim, constipation and delay of postoperative early recovery. Recently, some studies have revealed that perioperative continuous intravenous lidocaine infusion improved postoperative outcomes in postoperative pain, consumption of opioid medications and length of hospital stay (LOS) [13] [14] [15] [16] . However, its effect on postoperative outcomes is not well identified due to their small sample and the deficiency of multicenter and large sample randomized controlled trials. Therefore, this review aimed to systematically assessed the effect of perioperative continuous intravenous lidocaine infusion in elderly patients undergoing surgery, in terms of postoperative pain control, postoperative opioid consumption, length of hospital stay, gastrointestinal (GI) recovery, opioid related adverse events such as postoperative nausea and vomiting (PONV) and postoperative neuropsychological function status scale.
Method

Protocol and registration
The protocol of this review was registered with the International Prospective Register of Systematic Reviews (PROSPERO) before we started to search. Preferred Reporting Items for Systematic Reviews and Meta-Analyses(PRISMA) statement [17] was followed in conducting and reporting this systematic review and meta-analysis by us (http://www.prisma-statement.org).
Eligibility criteria
All randomized controlled trials (RCTs) studies included were that evaluated the effect of perioperative lidocaine continuous intravenous infusion comparing with placebo, saline or blank control on at least one of relevant outcome of our interest. The intravenous lidocaine infusion must have been started preoperatively or intraoperatively (with or without an intravenous bolus) and continued until the end of surgery or a period of postoperation.
Searched database resource
Two authors independently searched electronic database Pubmed/Medline, Web of
Science, Embase and Cochrane Central Register of Controlled Trials (CENTRAL) through
Ovid SP from the time of database construction to 10 November, 2019. A subject-specific search strategy was developed using in Pubmed/Medline and applied that as the basic of the search strategies in the other electronic databases. We also scanned the reference lists and citations of included trials and any relevant systematic reviews referred to further literatures to additional trials. If necessary, we contacted trial authors to achieve additional information. We did not apply any restrictions to language and the type of surgery when searching. The literature search strategy was provided in additional file: appendix 1.
Study selection
We included the study which conformed to the following criterias: .At least containing one of the outcomes of our interest and whose relative data can be exacted Two authors respectively scanned the title and abstract of identified records to exclude uncorrelated studies and accessed the full-text articles for eligibility. We resolved any disagreements in each step by discussion or consulting the arbiter.
Data extraction
Two authors independently exacted the data of all of the included studies using standard data exaction form prepared by authors, which contained the first author, published year, study design, surgery type, population characteristics, details of lidocaine infusion and reported outcomes of our interest. If necessary, we contacted the authors of included studies by email to achieve the additional data that were missing in published. If additional information was not received, we exacted data and information from the figures. At each step of exacting data, we resolved any divergences by discussion or consulting arbiter.
Primary outcomes
1.Postoperative pain intensity
Pain score at rest, cough and movement (0 to10cm, 0 to 100mm visual analogue scale 
Risk of bias in individual studies
Two authors respectively assessed the risk of bias of all included studies. The Cochrane risk of bias tool was used to assess the risk of bias of included studies and each component was judged as low risk of bias (green), high risk of bias (red) or unclear risk of bias (yellow) and the result was shown in Fig. 2 .
Summary measures and synthesis of results
For the outcome of the post-operation opioid consumption, all various opioid qualities was converted to intravenous morphine equivalent (MEQ, mg) to describe the consumption of opioid (http://www.whocc.no/atc_ddd_index).
For outcome PONV, we respectively assessed two outcomes:
1.Postoperative nausea containing PONV: if postoperative nausea and postoperative vomiting were not separately published.
2.Postoperative vomiting: if postoperative vomiting was independently reported.
When the mean and standard difference (SD) were not reported and were not obtained by contacting the relevant authors as soon as possible, they were calculated by using the median and standard error (SE) or confidence interval (CI), or the interquartile rang (IQR) if the data distribution was symmetrical [18] .
Data were analyzed using Review Manager, version 5.3.5 (RevMan, The Cochrane Collaboration, Oxford, United Kingdom).
For continuous data, if studies measured data on the same way and scale, the mean difference (MD) was obtained from the difference between experimental group and control group with mean values and SD and if studies assessed the same outcome but measured it with different scales or ways, the standardized mean difference (SMD) was used.
For dichotomous outcomes, the odds ratio (OR) was assessed from experimental and control group event rates and 95%CI was calculated.
Random effect model was use to analysis the combined data which was assumed that clinical heterogeneity existed. The I 2 statistics was used to report the heterogeneity, which was classified by applying Cochrane Handbook of Systematic Reviews of Interventions and when I 2 >50%, it was considered the existence of obvious heterogeneity.
Further, if I 2 >50%, a several subgroup analyses and sensitivity analysis were conducted to evaluate the source of heterogeneity and to assess the subpopulation of patients that could probably obtain benefits from the intervention. Subgroup analysis was performed in outcomes of length of hospital stay grouped by the type of surgery and sensitivity analysis was performed in postoperative pain score. Funnel plots were used to check the publication bias.
Result
Search result
We present the results of literature search in a PRISMA flow chart ( Fig. 1) . 3789 records were identified through database searching. After duplicating, screening the initial title and abastract,81 full texts were retrieved for comprehensive evaluation. Finally, 18 RCTs were included which contained 1175 patients met the inclusion criteria in the present meta-analysis included in the final analyses.
Study characterizes
The patients of these 18 RCTs whose average age older than 60. These articles contained 595 patients in lidocaine groups and 580 patients who received normal saline or nothing served as control. Studies were carried through in patients undergoing abdominal, cardiac, orthopedic, urinary, endoscopic surgery. Nine of the studies reported surgery time, and all studies mentioned duration of infusion. A lidocaine bolus (1-2mg/kg) was given before surgical incision in 17 of the 18 RCTs whereas all eligible RCTs followed by a continuous infusion during and after operation. The characteristics of the included trials were summarized in Table 1 .
Risk of bias within studies
We evaluated the quality of the included RCTs on the basis of the Cochrane Handbook of Systematic Reviews of Interventions, version 5.1.0 (updated March 2011) [18] .The entire risk of bias concerning selection bias, performance bias, attrition bias, detection bias and other bias exposed low risk of bias in more than 65% across all included all studies ( Fig. 2 and Fig. 3 ).
Primary outcomes
Postoperative pain
Postoperative pain was evaluated by different pain scores. The pain scores were provided in totally 11 studies of 18 RCTs which had sufficient quantitative data to be combined through meta-analysis [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] .Five studies assessed postoperative pain on a visual analogue scale (VAS) from 0 to 100mm and five studies used the VAS from 0 to 10cm measurement, while one trial evaluated postoperative pain with NRS.
Pain score at rest
As shown in Fig. 4 , postoperative pain scores at rest were evaluated in 10 studies [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] .Meta-analysis of pain data at rest was statistically significant decrease VAS scores in lidocaine group compared with the control group at 2h (7 studies, n=386, SMD -1.30 95%CI -1.90 to -0.70), at 4h (7 studies, n=364, SMD -1.20 95%CI -1.91 to -0.49), at 6h (3 studies, n=208, SMD -0.87 95%CI -1.72 to -0.02), at 8h (5 studies, n=284, SMD -0.84 95%CI -1.40 to -0.27), at 12h (4 studies, n=267, SMD -0.73 95%CI -1.14 to -0.32), at 18h (3 studies, n=208, SMD -0.79 95%CI -1.78 to 0.20), at 24h (10 studies, n=569, SMD -0.39 95%CI -0.66 to -0.11), at 48h (8 studies, n=458, SMD -0.25 95%CI -0.59 to 0.10). The outcome adequately revealed that perioperative intravenous lidocaine infusion can reduced postoperative pain scores in elderly patients of abdominal, cardiac, orthopedic, urinary, endoscopic surgery at 2h, 4h, 6h,8h, 12h, 24h after surgery, but did not decreased the pain scores at 18h and 48h after surgery.
Pain score at movement
There were 4 trials reported the pain scores postoperatively at movement [22] [23] [24] 29] .The pain score at movement after surgery was decreased with intravenous lidocaine at 2h (2 studies, n=151, SMD -1.02 95%CI -2.05 to -0.00), 12h (2 studies, n=151, SMD -0.84 95%CI -1.18 to -0.51), one study of Moeen [24] demonstrated yield similar effect at 6h (n=111, SMD -1.42 95%CI -1.84 to -1.01) and at 18h (n=111, SMD -0.70 95%CI -1.09 to -0.32); although there was no statistical differences at 4h (1 studies, n=40, SMD -0.58 95%CI -1.21 to 0.05), at 24h (4 studies, n=277, SMD -0.10 95%CI -0.51 to 0.30), at 48h (4 studies, n=277, SMD -0.15 95%CI -0.56 to 0.26).The detailed result are showed in Fig. 6 .
We performed the robust of the evidence by sensitivity analysis, The difference of the combined effect was detected by different effect model. The estimated effect(95%CI) for the sensitivity analysis remained robust about the pain scores at different point times from 2h to 48h after surgery when selecting random effect model or fixed effect model, which showed that the results were reliable.
2.Length of hospital stay
17 trials [19] [20] [21] [22] [23] [24] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] of 18 RCTs reported the length of hospital stay between groups. The overall pooled results from the meta-analysis showed that lidocaine markedly shortened the time of hospital stay compared with the control group. Intervention substantial heterogeneity was noted (MD -0.30 95%CI -0.50 to -0.09); forest plot is shown in Fig. 7 .
In 3 studies [26, 32, 34] of the 18 RCTs, lidocaine in cardiac surgery as the intervention was effective in shorting duration of hospital stay (MD -0.71 95%CI -1.37 to -0.05); Nevertheless, results from 8 studies [19-22, 28, 29, 35, 36] in gastrointestinal surgery were not shown to reducing length of hospital stay (MD -0.20 95%CI -0.54 to 0.14) ;6 studies [23, 24, 27, 30, 31, 33] in other surgery revealed yielded lidocaine infusion can decreased the length of hospital stay (MD -0.30 95%CI -0.50 to -0.09).
Secondary outcomes
Postoperative opioid consumption
Eleven articles with 552 patients reported the outcome of postoperative opioid consumption. Morphine was applied for postoperative pain relief in 6 trials [20, 23, 25, 27, 30, 33] , 4 trials [19, 21, 26, 28] applied fentanyl, one trial [29] offered meperidine. Pooled metaanalysis revealed the lidocaine group had fewer opioid requirements (MEQ, mg) after surgery in comparison to the control group (SMD -0.31 95%CI -0.61 to -0.01).
Gastrointestinal recovery
Six studies [20, 25, 29, 30, 33, 35] with 285 patients reported data on the time to first flatus and the time to first defaecation/bowel movement.
Time to first flatus
The combined analysis did not demonstrate a significant reduction of time to flatus in lidocaine group compared with the control group (MD -3.24 95%CI -9.90 to 3.41).
Time to first defaecation/bowel movement
There was enough evidence of effect for lidocaine infusion in contrast with the control group to shorten the time to first defaecation/bowel movement (MD -8.64 95%CI -16.00 to -1.28).
Postoperative neuropsychological function status scale
Only one studies [34] proved lidocaine administration during and after surgery does not reduce the high rate of postoperative cognitive dysfunction.
Adverse events
The complication of nausea was reported in 9 trials [19, 21, 22, 27-29, 33, 35, 36] ,whereas three articles [19, 21, 28] showed the complication of vomiting. It illustrated respectively that there was significant reduction in nausea in lidocaine group contrasted with control group (n=479 OR 0.56 95%CI 0.37 to 0.84). There was no statistical difference about vomiting between lidocaine group and control group (n=120 OR 0.47 95%CI 0.19 to 1.1) but there was a slightly lower incidence of vomiting in lidocaine group when compared with the control group.
Risk of bias across studies
The funnel plot was used to investigated the risk of bias across studies (publication bias).
For outcome of postoperative pain, the funnel plot at 24h after surgery suggested funnel plot asymmetry on visual inspection, publication bias was likely to be present (Fig. 5 ). The funnel plot for the duration of hospital stay suggested funnel plot was symmetrical on visual inspection, indicating that publication bias was not likely to be present (Fig. 8 ).
Additional analysis
Additional analyses such as subgroup analysis, sensitivity analysis and publication bias analysis were performed to evaluate which surgery may benefit from IV lidocaine administration (subgroup analysis), the robust of result in terms of risk of bias from single study (sensitivity analysis) and the appearance of risk of bias across analysis (publication bias). By this means we researched the primary outcome, such as subgroup analysis for length of hospital stay, sensitivity analysis for postoperative pain at 24h after surgery and publication bias analysis for length of hospital stay and postoperative pain at 24h after surgery.
1.
Subgroup analysis. The preplanned subgroups analysis on type of surgery accounted for heterogeneity about all subgroups ( Fig. 7) . Subgroup analysis was conducted and it was shown that IV lidocaine short the length of hospital stay only in cardiac surgery subgroup and other surgery subgroup compared to control, however, in gastrointestinal surgery subgroup, it was not statistical difference, which may be resulted by the small effect of IV lidocaine in shortening length of hospital stay for aged patients and a weaker physiological state in old folks , however, heterogeneity of three group was accepted (I 2 <50%). This result indicated that aged patients undergoing cardiac surgery may more likely benefit from perioperative IV lidocaine and the debate that whether perioperative IV lidocaine shorten the length of hospital stay in aged patients undergoing gastrointestinal surgery may resolved by more high qualities and large simple size RCTs in the future. other meta-analysis [37, 38] result of IV lidocaine comparing to control group that was IV lidocaine reduce length of hospital stay in adult undergoing gastrointestinal surgery. It might explain the opposite result that aged patient is enormously different from adult in physiology, psychology and any other fields. Furthermore, there is a lower incidence of adverse event of opioid related, postoperative nausea, in the lidocaine group.
Nevertheless, there is no statistical significance in postoperative vomiting between IV lidocaine group and control group. In addition, there was less requirement of opioid consumption in IV lidocaine group compared to placebo or no treatment of control group and there was a lower risk of postoperative nausea, which is related to opioid using to some extent.
The mechanism of potential analgesia effect and other potential benefits of IV lidocaine remains unclear [39] . Two explanations that were selective suppression of pain transfer in spinal marrow and blocking the sodium channel of mechanosensitive nociceptor have been reported to interpret the mechanism of reduction pain of IV lidocaine. In addition, IV lidocaine has also revealed anti-inflammatory benefits [40] .Previous studies have demonstrated that IV lidocaine reduced the level of inflammatory mediators [41] .
Therefore, the mechanism that IV lidocaine reduce postoperative pain require more animal experiments and clinical trials to provide a stronger evidence.
Perfect postoperative analgesia benefits early rapid postoperative recovery and reduction of postoperative complications. However, single model analgesia is adequate for aged patients after surgery and multimodal analgesia is recommended to decrease postoperative pain intensity, opioid consumption and short length of hospital stay. Some published articles [13, [42] [43] [44] have shown that IV lidocaine reduced pain and shorten length of hospital stay, in addition, there was a lower inflammatory in IV lidocaine and lower risk of postoperative nausea and vomiting. Thus, IV lidocaine was more preferred to use in intraoperation and after surgery. In our review, the length of hospital stay of IV lidocaine compared to control group was statistical difference, however, the heterogenicity was large, which was contrast to some articles and meta-analyses [9, 24, 45] . Thus, subgroup analysis was conducted and it was shown that IV lidocaine short the length of hospital stay only in cardiac surgery subgroup and other surgery subgroup compared to control, however, in gastrointestinal surgery subgroup, it was not statistical difference. It might explain the opposite result that aged patient is enormously different from adult in physiology, psychology and any other fields.
Furthermore, it might be explained that the studies included are single center and small sample size study.
Although a massive of studies [20, 34, 35, 46] have affirmed that the IV lidocaine was associated with a opioid-sparing effect in geriatric patients undergoing surgery, there was lack of dependable evidence. Meta-analysis can enhance statistical power and enlarger sample size by uniting results of previously published studies, which could provide a stronger evidence. Our present meta-analysis indicated that perioperative IV lidocaine could significantly reduce postoperative pain intensity, length of hospital stay in cardiac surgery, opioid consumption and postoperative nausea.
Limitations
In order to reduce the risk of bias of this present meta-analysis, we included only RCTs which all were high qualities evidence. However, there were some potential limitations in this study. And what we mentioned above may be the one resource of the heterogeneous in this review.
Thirdly, the heterogeneous outcome published was also a limitation. Although subgroup and sensitivity analysis was performed to make it lower, however, not all planned subgroup and sensitivity analysis could be carry out due to insufficient data reported.
Thus, the heterogeneity could not always be explicated. At last, the range of published
year of all included studies was large, which was from 1995 to 2019. Interquartile rang
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Figure 2
Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
Figure 3
Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
Figure 4
The forest plot for pain score at rest between lidocaine and control groups by time points Figure 5 The funnel plot for pain score of 24h at rest between lidocaine and control groups Figure 6 The forest plot for pain score at movement between lidocaine and control groups by difference time points The forest plot for length of hospital stay outcome between lidocaine and control groups by type of surgery
